CD19 and major depressive disorder: Another strength is our study based on machine learning techniques to explore CD19+ B cell counts, CD3+ T cell counts, CD3–CD16/56+ NK cell counts, and total lymphocyte counts as new predictors to differentiate BD and MDD.